Skip to main content
. Author manuscript; available in PMC: 2016 May 5.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):561–565. doi: 10.1097/PAI.0b013e31824e93f2

Figure 1.

Figure 1

Composite pictures of H&E and immunohistochemistry for MIST1 and CD138.

A. H&E of CD138 negative plasmablastic lymphoma (400× magnification).

B. MIST1 of CD138 negative plasmablastic lymphoma (400× magnification).

C. CD138 of CD138 negative plasmablastic lymphoma (400× magnification).

D. H&E of Lymphoplasmacytic lymphoma (400× magnification).

E. MIST1 of Lymphoplasmacytic lymphoma (400× magnification).

F. CD138 of Lymphoplasmacytic lymphoma (200× magnification).

G. H&E of Marginal Zone Lymphoma (400× magnification).

H. MIST1 of Marginal Zone Lymphoma (400× magnification).

I. CD138 of Marginal Zone Lymphoma (400× magnification).

J. H&E of Plasma cell neoplasm (400× magnification).

K. MIST1 of Plasma cell neoplasm (400× magnification).

L. CD138 of Plasma cell neoplasm (400× magnification).

M. H&E of Plasmablastic lymphoma (400× magnification).

N. MIST1 of Plasmablastic lymphoma (400× magnification).

O. CD138 of Plasmablastic lymphoma (400× magnification).

P. H&E of normal bone marrow (400× magnification).

Q. MIST1 of normal bone marrow (400× magnification).

R. CD138 of normal bone marrow (400× magnification).

S. MIST1 of Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma (400× magnification).

T. MIST1 of Follicular lymphoma (200× magnification).

U. MIST1 of Mantle cell lymphoma (400× magnification).